Science Explorer Interactive view Map
Nonprofit · Paris · France

Groupe Francophone des Myélodysplasies

Research works
52
▲ 53% vs 2013–17
Citations
880
17.0 per fractional work
Top-10% rate
18.5%
record average 16.5%
Open access
19%
world 28%

Not ranked overall: Groupe Francophone des Myélodysplasies is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.37× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.25× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 0.79× its world share, 0 worksImmunology and Micro…Neuroscience: 0.66× its world share, 0 worksNeuroscienceComputer Science: 0.05× its world share, 0 worksComputer ScienceEngineering: 0.06× its world share, 0 worksEngineeringEnvironmental Science: 0.74× its world share, 0 worksEnvironmental ScienceHealth Professions: 0.35× its world share, 0 worksHealth ProfessionsMedicine: 3.56× its world share, 4 worksMedicineNursing: 1.09× its world share, 0 worksNursingDecision Sciences: 4.98× its world share, 0 worksDecision Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Decision Sciences, 5.0×. Every wedge is a field page.

Which keywords describe research at Groupe Francophone des Myélodysplasies?

By fractional works in all years, weighted toward what it does more of than the world: Prognostic Factors, Hematopoietic Stem Cells, Acute Myeloid Leukemia, AML, Rituximab, Therapeutic Targets, Minimal Residual Disease and Chronic Lymphocytic Leukemia.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Prognostic Factors15▲ 64×5 topics
  2. Hematopoietic Stem Cells11▲ 202×3 topics
  3. AML9▲ 363×1 topic
  4. Acute Myeloid Leukemia9▲ 363×1 topic
  5. Rituximab5▲ 61×3 topics
  6. Minimal Residual Disease5▲ 132×2 topics
  7. Therapeutic Targets5▲ 37×2 topics
  8. Chronic Lymphocytic Leukemia4▲ 176×1 topic
  9. Genomic Aberrations4▲ 176×1 topic
  10. Epidemiology4▲ 2.0×15 topics
  11. Inflammation4▲ 3.0×19 topics
  12. Diagnosis Criteria3▲ 196×1 topic
  13. International Myeloma Working Group3▲ 196×1 topic
  14. Proteasome Inhibitors3▲ 86×2 topics
  15. Prognostic Scoring System3▲ 153×2 topics
  16. JAK2 Mutation3▲ 254×1 topic
  17. Myelofibrosis3▲ 254×1 topic
  18. Anemia2▲ 39×3 topics
  19. Diagnosis2▲ 4.4×12 topics
  20. Treatment2▲ 3.2×11 topics
  21. Genetic Mutations2▲ 7.1×3 topics
  22. Pancreatic Cancer2▲ 30×2 topics
  23. Alloimmunization2▲ 92×1 topic
  24. Blood Groups2▲ 92×1 topic
  25. Sickle-cell Disease2▲ 73×1 topic
  26. Thalassemia2▲ 73×1 topic
  27. Mutation2▲ 19×2 topics
  28. Acute Lymphoblastic Leukemia2▲ 79×1 topic
  29. BCR-ABL2▲ 106×1 topic
  30. Childhood Cancer2▲ 79×1 topic
  31. Imatinib2▲ 106×1 topic
  32. Bone Marrow Niche1▲ 73×1 topic
  33. Graft-versus-Host Disease1▲ 73×1 topic
  34. Guidelines1▲ 5.1×7 topics
  35. Immune Dysregulation1▲ 30×1 topic
  36. Primary Immunodeficiency1▲ 61×1 topic
  37. Thrombosis1▲ 11×4 topics
  38. Antiretroviral Therapy1▲ 9.5×2 topics
  39. Cognitive Impairment1▲ 8.6×2 topics
  40. Hemostasis1▲ 13×2 topics

Which research topics does Groupe Francophone des Myélodysplasies publish most on?

By volume in 2022–2025: Acute Myeloid Leukemia Research, Enhanced Recovery After Surgery, Clinical practice guidelines implementation and Meta-analysis and systematic reviews.

  1. 1 Acute Myeloid Leukemia Research Hematology 1 works
  2. 2 Enhanced Recovery After Surgery Surgery 0 works
  3. 3 Clinical practice guidelines implementation Public Health, Environmental and Occupational Health 0 works
  4. 4 Meta-analysis and systematic reviews Statistics, Probability and Uncertainty 0 works
  5. 5 Chronic Myeloid Leukemia Treatments Hematology 0 works
  6. 6 Lepidoptera: Biology and Taxonomy Genetics 0 works
  7. 7 Minimally Invasive Surgical Techniques Surgery 0 works
  8. 8 Appendicitis Diagnosis and Management Emergency Medicine 0 works
  9. 9 Abdominal Surgery and Complications Pulmonary and Respiratory Medicine 0 works
  10. 10 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available18.7%not open81.3%

World: 28% of research is openly available.

with international co-authors25.9%domestic only74.1%

World: 19% is written across borders.

How has Groupe Francophone des Myélodysplasies's research output changed?

Output in 2018–2022 was 53% higher than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Paris

All research institutions in Paris

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.